Jeil Pharmaceutical Co.,Ltd
KRX:271980.KS
14950 (KRW) • At close October 18, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||
| Nettowinst
| 5,004.745 | -15,009.014 | -14,985.618 | 6,964.802 | -10,584.593 | 1,889.033 | 1,067.595 | 7,890.255 | 9,761.371 |
| Afschrijvingen & Amortisatie
| 9,767.1 | 8,886.235 | 9,132.602 | 8,992.862 | 7,605.968 | 6,625.367 | 3,863.464 | 7,680.337 | 8,464.657 |
| Uitgestelde Inkomstenbelasting
| -48,210.012 | 0 | 8,470.415 | 3,376.605 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 578.027 | 472.48 | 163.169 | 80.042 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -20,688.837 | -15,155.225 | 14,617.072 | -39,787.71 | 21,565.492 | 7,109.136 | -13,245.588 | -5,565.888 | -15,941.493 |
| Vorderingen
| -9,903.336 | -6,044.103 | 10,649.883 | 5,165.943 | 11,809.525 | 28,291.744 | -2,960.018 | 1,356.466 | -16,444.038 |
| Voorraden
| -10,574.679 | 3,562.01 | 6,334.108 | -26,617.624 | 4,236.538 | -5,390.501 | -2,105.627 | -6,761.028 | -14,818.098 |
| Crediteuren
| -7,619.77 | -1,664.182 | 9,624.671 | -6,487.251 | 4,791.412 | -2,074.338 | -7,484.647 | 10,479.636 | 21,826.425 |
| Overig Werkkapitaal
| 7,408.948 | -11,008.95 | -11,991.59 | -11,848.778 | 728.017 | 12,499.637 | -11,139.96 | -10,640.962 | -6,505.782 |
| Overige Niet-Contante Posten
| 48,568.299 | 5,658.534 | 1,702.606 | 1,327.312 | 10,370.757 | 5,829.816 | 4,104.735 | 11,643.798 | 26,823.664 |
| Kasstroom uit Operationele Activiteiten
| -4,980.678 | -15,146.99 | 19,100.246 | -19,046.087 | 28,957.624 | 21,453.352 | -4,209.794 | 11,362.902 | 2,743.174 |
| Investeringsactiviteiten: | |||||||||
| Investeringen in Materiële Vaste Activa
| -9,575.861 | -16,958.19 | -5,392.637 | -2,866.951 | -1,395.783 | -10,286.514 | -3,998.555 | -30,326.528 | -7,052.915 |
| Netto Overnames
| 87.636 | 26,010.553 | -1,499.999 | 599.995 | -307.308 | 95.323 | -3,017.6 | 4,510.767 | 37.516 |
| Aankoop van Beleggingen
| -5,555.31 | -26,010.553 | -1,908.568 | -3,540.246 | -184.998 | -350 | -21.254 | -3,489.836 | -5,106.344 |
| Verkoop/verval van Beleggingen
| 3,031.111 | 1,897.604 | 654.526 | 28.236 | 350 | 0 | 12.85 | 3,815.41 | 6,835.021 |
| Overige Investeringsactiviteiten
| 93.808 | 2,136.464 | 109.518 | 201.989 | 392.035 | 228.044 | -621.518 | 605.8 | 1,287.5 |
| Kasstroom uit Investeringsactiviteiten
| -11,918.615 | -12,924.123 | -8,037.159 | -5,576.976 | -1,146.054 | -10,408.47 | -7,646.077 | -24,884.387 | -3,999.221 |
| Financieringsactiviteiten: | |||||||||
| Schuldaflossingen
| -21,696.2 | -5,156.25 | -12,378.229 | -6,125 | -16,973.333 | -23,935.046 | -15,240.2 | -30,612.3 | -10,718.4 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | -2,218.256 | 38 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | -396.983 | -810.022 | -314.879 | -2,995.238 | -78.553 | -233.291 | 0 | -3,124.485 |
| Uitgekeerde Dividenden
| -728.378 | -947.735 | -1,022.339 | -1,022.69 | -875.45 | -734.835 | 0 | -764.193 | -772.813 |
| Overige Financieringsactiviteiten
| 41,190.098 | 40,118.836 | 27,497.6 | 22,557.653 | 4,255.006 | 0 | 15,240.242 | 0 | 0 |
| Kasstroom uit Financieringsactiviteiten
| 18,765.52 | 33,617.868 | 11,068.755 | 15,133.084 | -16,589.015 | -24,748.433 | 15,006.952 | 29,848.128 | 6,821.072 |
| Overige Informatie: | |||||||||
| Effect van Wisselkoersveranderingen op Kas
| -321.575 | -63.8 | -62.036 | -131.817 | -202.625 | -9.351 | -147.135 | 0 | 0 |
| Netto Kasstroomverandering
| 1,544.652 | 5,482.955 | 22,069.805 | -9,621.797 | 11,019.93 | -13,712.901 | 3,003.946 | 16,326.643 | 5,565.025 |
| Kaspositie aan het Einde van de Periode
| 32,990.886 | 31,446.234 | 25,963.279 | 3,893.474 | 13,515.271 | 2,495.34 | 16,208.242 | 30,078.663 | 13,538.06 |